Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...
Zacks Research Issues Negative Forecast for TROW Earnings
Equities research analysts at Zacks Research cut their Q1 2025 earnings estimates for shares of T. Rowe Price Group in a note ...
Zacks Research Has Negative Outlook for MOH FY2025 Earnings
Research analysts at Zacks Research decreased their FY2025 earnings per share (EPS) estimates for shares of Molina Healthcare ...
Zacks.com on MSN2hOpinion
Best Income Stocks to Buy for March 4th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 4th: Independent ...
Esperion Therapeutics: Q4 Earnings Snapshot
Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $21.3 million in its fourth quarter. The Ann Arbor, Michigan-based company said it had a loss of 11 cents per share. Losses, adjusted to ...
On Holding: Q4 Earnings Snapshot
The Zurich-based company said it had profit of 31 cents per share. Earnings, adjusted for stock option expense, were 38 cents per share. The results topped Wall Street expectations. The average ...
Tom's Guide on MSN17d
12 million hit in Zacks Investment data breach — how to protect yourself now
As reported by Bleeping Computer, an underground hacking forum thread from January has been discovered which claims that Zacks has fallen victim to yet another data breach. This latest breach, the ...
The Zacks Analyst Blog Highlights Palantir, C3.ai, Microsoft and Alphabet
Another SaaS company, C3.ai, Inc., providing AI-based applications, has become a Wall Street darling as it continues to get a ...